2018 CONGRESS SPEAKERS

 

DOWNLOAD THE 2018 POST EVENT REPORT
REGISTER YOUR INTEREST FOR 2019

2018 Event Partners

2018 CONGRESS SPEAKERS

 

 

Chandra P Leo

Chandra P Leo

Investment Advisor
HBM Partners
Hubert Birner

Hubert Birner

Managing Partner
TVM CAPITAL LIFE SCIENCE
Sander Slootweg

Sander Slootweg

Managing Director
Forbion Capital Partners
Kate Bingham

Kate Bingham

Managing Partner
SV LIFE SCIENCES
Iain Dukes

Iain Dukes

Venture Partner
ORBIMED
Paul Saunders

Paul Saunders

Head of Innovation Investments
Ireland's Strategic Investment Fund
Alain Huriez

Alain Huriez

Chairman and Managing Partner
Advent France Biotechnology
Iain Thomas

Iain Thomas

Head of Life Sciences
Cambridge Enterprise
Paul Ashley

PAUL ASHLEY

Head of Technology Transfer
Oxford University Innovation
Tony Hickson

TONY HICKSON

Managing Director, Tech Transfer
Imperial Innovations
Pascale Auge

Pascale Auge

CEO
INSERM TRANSFERT
Viktor Drvota

VIKTOR DRVOTA

CEO
Karolinska Development
Giovanni Mariggi

Giovanni Mariggi

Principal
Medicxi
Deborah Harland

Deborah Harland

Partner
SR-ONE
Dirk Kersten

DIRK KERSTEN

Managing Director
INKEF CAPITAL
Jonathan Goldstein

JONATHAN GOLDSTEIN

Director, Corporate Research and Ventures
Boston Scientific Ventures
Nissim Darvish

Nissim Darvish

Senior Managing Director
Orbimed
Piyush Unalkat

Piyush Unalkat

Head of Technology Transfer
EIF
Gerry Maguire

Gerry Maguire

General Partner
Atlantic Bridge
Soren Moller

Soren Moller

Managing Partner
Novo Seeds
Frank Hensel

Frank Hensel

Senior Investment Manager
High-Tech Grunderfonds
sample-1

Edward Van Wezel

Managing Partner
BioGeneration Ventures
Edoardo Negroni

Edoardo Negroni

Managing Partner
AurorA-TT
sample-1

John Zai

CEO
Cocoon Networks
Claudio Rumazza

Claudio Rumazza

Partner
Innogest
Christoph Ruedig

Christoph Ruedig

Partner
Albion Capital
Alexia Perouse

Alexia Perouse

CEO
iBionext Growth Fund
Martin Pfister

Martin Pfister

Senior Investment Manager
High-Tech Grunderfonds
sample-1

Johnston Erwin

VP, Corporate Business Development
Eli Lilly & Co
sample-1

Jasper Bos

VP, Head of the Healthcare
Merck Ventures
Onno Van De Stolpe

Onno Van De Stolpe

CEO
Galapagos
Darrin Disley

Darrin Disley

CEO
Horizon Discovery Group
Edwin Moses

Edwin Moses

CEO
Ablynx
Joachim Rautter

Joachim Rautter

Managing Director
Peppermint
Daniel O'Mahony

Daniel O'Mahony

Partner
Seroba Life Sciences
Thom Rasche

Thom Rasche

Partner
EARLYBIRD Venture Capital
Janke Dittmer

Janke Dittmer

Partner
Gilde Healthcare
Tim Luker

Tim Luker

Senior Director, Emerging Technology and Innovation, Business Development
Eli Lilly & Co.
Timothy Herpin

Timothy Herpin

VP and Head of Transactions and BD
AstraZeneca
Hans Loibner

Hans Loibner

CEO
APEIRON Biologics
James Shaw

James Shaw

Co-Founder
JAG SHAW BAKER
Jennifer Laird

Jennifer Laird

Senior Director, Neuroscience & CNS
Eli Lilly & Co.
Martin Frost

Martin Frost

CEO
Cambridge Medical Robotics
Tommi Lehtonen

Tommi Lehtonen

CEO
Blueprint Genetics
Billy Boyle

Billy Boyle

CEO
Owlstone Medical
Steve Atkinson

Steve Atkinson

CEO
ATLANTIC THERAPEUTICS
Sarah Howell

Sarah Howell

CEO
Arecor
Neil Clark

Neil Clark

CEO
Destiny Pharma
Richard Davies

Richard Davies

CEO
Bone Support
Jean-Philippe Combal

Jean-Philippe Combal

CEO
Vivet Therapeutics
Rob De Ree

Rob de Ree

Chairman
Mellon Medical
Marc Lemonnier

Marc Lemonnier

CEO
Antabio
Pierre Chauvineau

Pierre Chauvineau

VP
Boston Scientific
Adam Hill

Adam Hill

CMO
McLaren Applied Technologies
Isobel Finnie

Isobel Finnie

Partner
Haseltine Lake
CHRISTOPH KAUSCH

CHRISTOPH KAUSCH

Founding Partner and CEO
MTIP MEDTECH INNOVATION PARTNERS
Pawel Przewiezlikowski

Pawel Przewiezlikowski

CEO
SELVITA

Isabel Van De Keere

CEO
Immersive Rehab
HENRI FRANCOIS-BOEDT

HENRI FRANCOIS BOEDT

Senior Loan Officer
EUROPEAN INVESTMENT BANK
DAVID BERRY

DAVID BERRY

General Partner
Flagship Pioneering
Elisa Petris

ELISA PETRIS

PARTNER
SYNCONA PARTNERS
Joe Anderson

Joe Anderson

CEO
Arix Biosciences
Philippe Lopes-Fernandes

Philippe Lopes-Fernandes

SVP, Head of Global Business Development & Alliance Management,
EMD SERONO
Naveed Siddiqi

Naveed Siddiqi

Partner
Edmond de Rothschild Investment Partners
David Hipkiss

David Hipkiss

CEO
ENESI PHARMA
ANDREW SHAILER-SMITH

ANDREW SHAILER-SMITH

CEO
ASTRAVEUS
Sourabh Pagaria

Sourabh Pagaria

Senior Vice President and General Manager, Enterprise Services & Solutions,
Siemens Healthineers
BEVERLEY CARR

BEVERLEY CARR

Business Development, Immunoinflammation Therapy Area
GSK
Xavier Bertrand

Xavier Bertrand

Global GM Symetis & VP International SH Valves
BOSTON SCIENTIFIC
NIELS RIEDEMANN

NIELS RIEDEMANN

CEO
INFLARX
Adam Kostyál

Adam Kostyál

SVP and Head of European Listings
NASDAQ
Asaf Homossany

Asaf Homossany

Managing Director, EMEA
NASDAQ
TIM HAINES

TIM HAINES

Managing Partner
ABINGWORTH
ELAINE WARBURTON

ELAINE WARBURTON

CEO
QUANTUMDX
ERICA WHITTAKER

ERICA WHITTAKER

HEAD OF UCB VENTURES
UCB PHARMA
NIALL MARTIN

NIALL MARTIN

CEO
ARTIOS PHARMA
SIMON HUBBERT

SIMON HUBBERT

CEO
LIG TECHNOLOGIES
TIM WILSON

TIM WILSON

CEO
IGEM THERAPEUTICS
sample-1

PAUL KO FERRIGNO

CEO
MetaLinear

SHAUN GRADY

VP GLOBAL BUSINESS DEVELOPMENT
ASTRAZENECA
 Timm Jessen

Timm Jessen

CEO
Topas Therapeutics
Jean Christophe Renondin

Jean Christophe Renondin

Senior Investment Manager Healthcare
Oman Investment Fund
Rainer Lichtenberger

Rainer Lichtenberger

CEO
Atriva Therapeutics
Assaf Barnea

Assaf Barnea

CEO
Sanara Ventures
Celine-Lea Halioua-Haubold

Celine-Lea Halioua-Haubold

CEO
OISIN Biotechnologies
Florence Sejourne

Florence Sejourne

CEO
Da Volterra
Patrick van Beneden

Patrick van Beneden

Partner
GIMV
James Greene

James Greene

CEO
Medlumics
Clive Cookson

Clive Cookson

Science Editor
Financial Times
Vanessa Malier

Vanessa Malier

Managing Partner
Kurma Partners
Tushar Singhvi

Tushar Singhvi

VP Corporate Development and Investments
Crescent Enterprises
Theresa Deisher

Theresa Deisher

CEO
AVM Biotechnology
Miguel Costa

Miguel Costa

CEO
Aglaris Cell
Rodger Novak

Rodger Novak

CEO
Crispr Therapeutics
sample-1

Christian Schetter

CEO
Rigontec
sample-1

Pavithra Sundaresan

Senior Director New Ventures and Transaction Lead
J & J Innovation
sample-1

Phil L'Huillier

Head European Innovation Hub
MSD
sample-1

Carlos De Sousa

CEO
Immunicium
sample-1

Fred Jacobs

CEO
TYG - Oncology
sample-1

Randolph Hubbell

CEO
Carmell Therapeutics
sample-1

Thomas Lienard

CEO
Bone Therapeutics
sample-1

Martin Ostermaier

CEO
Interax
sample-1

Raúl Insa

CEO
SOM Biotech
sample-1

Tauhid Ali

VP Head of TAK-celerator
Takeda
sample-1

Christopher Cleary

VP Corporate Development
Medtronic
sample-1

Pekka Simula

CEO
Herantis Pharma
sample-1

Michael Stein

CEO
Oxstem
sample-1

Angus Grant

SVP Business Development
Celgene
sample-1

Gita Dittmar

Head of Corporate Development
Ethris
sample-1

Tara Raveendran

Head of Life Sciences Research
Shore Capital
Andrew Chapman

Andrew Chapman

Digital Health Sector Lead
Digital Catapult
John Hodgson, Data Editor, Pharma, SCRIP Pharma Intelligence

John Hodgson

Data Editor
SCRIP Pharma Intelligence
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Maria Dahl, Executive Director, Business Development, Oncology, AstraZeneca

Maria Dahl

Executive Director & Business Development
AstraZeneca
Anna Williamson, Oncology Business Development, Genentech Partnering

Anna Williamson

Oncology Business Development
Genentech Partnering
Jennifer Smith-Parker, Editor, EMEA, BioPharm Insight

Jennifer Smith-Parker

Editor EMEA
BioPharm Insight
Madeleine Armstrong, Reporter, EP Vantage

Madeleine Armstrong

Reporter
EP Vantage
Lisa Urquhart, Editor, EP Vantage

Lisa Urquhart

Editor
EP Vantage
Elizabeth Cairns, Medtech Reporter, EP Vantage

Elizabeth Cairns

Medtech Reporter
EP Vantage
Erik Milch, Partner, Cooley

Erik Milch

Partner
Cooley
Jacob Plieth, Senior Reporter, EP Vantage

Jacob Plieth

Senior Reporter
EP Vantage
Adrian Dawkes, Managing Director, PharmaVentures

Adrian Dawkes

Managing Director
Pharma Ventures
Tina Tan, Editor-in-Chief, Medtech Insight

Tina Tan

Editor-in-Chief
Medtech Insight
Julie Simmonds, Director, Equity Research, Panmure Gordon

Julie Simmonds

Director, Equity Research
Panmure Gordon
Ian Jones

Ian Jones

Patent Attornery
GILL JENNINGS & EVERY